Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander J Robins

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Atherosclerosis|March 13, 2013
Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudySander J Robins, Asya Lyass, Robert W Brocia, et al.
The Journal of Nutrition|May 25, 2012
Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older AmericansWilliam S Harris, James V Pottala, Ramachandran S Vasan, et al.
The American Journal of Cardiology|March 4, 2008
Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort)William B Kannel, Ramachandran S Vasan, Michelle J Keyes, et al.
Circulation|November 26, 2009
Relations of lipid concentrations to heart failure incidence: the Framingham Heart StudyRaghava S Velagaleti, Joseph Massaro, Ramachandran S Vasan, et al.
American Heart Journal|December 3, 2014
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart StudyCharlotte Andersson, Asya Lyass, Ramachandran S Vasan, et al.
Metabolism: Clinical and Experimental|December 15, 2007
Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention TrialBela F Asztalos, Dorothea Collins, Katalin V Horvath, et al.
Atherosclerosis|June 26, 2012
Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart StudyWilliam S Harris, James V Pottala, Sean M Lacey, et al.
Circulation|December 2, 2009
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the communityRamachandran S Vasan, Michael J Pencina, Sander J Robins, et al.
Diabetes Care|April 30, 2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)Sander J Robins, Hanna Bloomfield Rubins, Fred H Faas, et al.
Atherosclerosis|September 2, 2006
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT)Angeliki Georgopoulos, Hanna Bloomfield, Dorothea Collins, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Atherosclerosis|March 13, 2013
Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart StudySander J Robins, Asya Lyass, Robert W Brocia, et al.
The Journal of Nutrition|May 25, 2012
Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older AmericansWilliam S Harris, James V Pottala, Ramachandran S Vasan, et al.
The American Journal of Cardiology|March 4, 2008
Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk (from the Framingham Offspring Cohort)William B Kannel, Ramachandran S Vasan, Michelle J Keyes, et al.
Circulation|November 26, 2009
Relations of lipid concentrations to heart failure incidence: the Framingham Heart StudyRaghava S Velagaleti, Joseph Massaro, Ramachandran S Vasan, et al.
American Heart Journal|December 3, 2014
Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart StudyCharlotte Andersson, Asya Lyass, Ramachandran S Vasan, et al.
Metabolism: Clinical and Experimental|December 15, 2007
Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention TrialBela F Asztalos, Dorothea Collins, Katalin V Horvath, et al.
Atherosclerosis|June 26, 2012
Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart StudyWilliam S Harris, James V Pottala, Sean M Lacey, et al.
Circulation|December 2, 2009
Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the communityRamachandran S Vasan, Michael J Pencina, Sander J Robins, et al.
Diabetes Care|April 30, 2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)Sander J Robins, Hanna Bloomfield Rubins, Fred H Faas, et al.
Atherosclerosis|September 2, 2006
Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT)Angeliki Georgopoulos, Hanna Bloomfield, Dorothea Collins, et al.
Pageof 5